The results described above indicated that CCNB2, CDC20 or MYBL2 was independent prognostic marker for overall survival and might play a significant role in determining glioma prognosis, and the association between CCNB2, CDC20, MYBL2 and GBM should be investigated further. The gene discussed is CDC20; the disease is glioblastoma.